122 related articles for article (PubMed ID: 8100195)
21. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Grenader A; Healy DP
Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
[TBL] [Abstract][Full Text] [Related]
22. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB
Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005
[TBL] [Abstract][Full Text] [Related]
23. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
[TBL] [Abstract][Full Text] [Related]
24. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
Findell PR; Wong KH; Jackman JK; Daniels DV
Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
[TBL] [Abstract][Full Text] [Related]
25. Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats.
Gleason SD; Yin T; Little SP; Delapp N; Witkin JM
Behav Pharmacol; 2011 Sep; 22(5-6):531-9. PubMed ID: 21836463
[TBL] [Abstract][Full Text] [Related]
26. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.
Elsworth JD; Lawrence MS; Roth RH; Taylor JR; Mailman RB; Nichols DE; Lewis MH; Redmond DE
J Pharmacol Exp Ther; 1991 Nov; 259(2):595-600. PubMed ID: 1682479
[TBL] [Abstract][Full Text] [Related]
27. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.
Taylor JR; Lawrence MS; Redmond DE; Elsworth JD; Roth RH; Nichols DE; Mailman RB
Eur J Pharmacol; 1991 Jul; 199(3):389-91. PubMed ID: 1680717
[No Abstract] [Full Text] [Related]
28. Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243.
Robertson HA; Peterson MR; Worth GG
Brain Res; 1992 Oct; 593(2):332-4. PubMed ID: 1360321
[TBL] [Abstract][Full Text] [Related]
29. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Smith HP; Nichols DE; Mailman RB; Lawler CP
Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
[TBL] [Abstract][Full Text] [Related]
30. The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
Nomoto M; Fukuda T
Adv Neurol; 1993; 60():119-22. PubMed ID: 8093574
[No Abstract] [Full Text] [Related]
31. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
Imperato A; Obinu MC; Gessa GL
Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
[TBL] [Abstract][Full Text] [Related]
33. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
35. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.
Gleason SD; Witkin JM
Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553
[TBL] [Abstract][Full Text] [Related]
36. Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.
Izenwasser S; Katz JL
Eur J Pharmacol; 1993 Jun; 246(1):39-44. PubMed ID: 8102607
[TBL] [Abstract][Full Text] [Related]
37. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
[TBL] [Abstract][Full Text] [Related]
38. Peripheral dopamine receptors.
Kohli JD
Am J Hypertens; 1990 Jun; 3(6 Pt 2):25S-28S. PubMed ID: 2143385
[TBL] [Abstract][Full Text] [Related]
39. Rearing conditions alter social reactivity and D1 dopamine receptors in high- and low-aggressive mice.
Gariépy JL; Gendreau PL; Mailman RB; Tancer M; Lewis MH
Pharmacol Biochem Behav; 1995 Aug; 51(4):767-73. PubMed ID: 7675857
[TBL] [Abstract][Full Text] [Related]
40. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
